In order to further explore the mechanism of CH treatment in the improvement of TNF-α-induced inflammation in 3T3-L1 cells, we investigated the effect of CH on the NF-κB and MAPK signaling pathway related to adipocyte inflammation. The gene discussed is NFKB1; the disease is cyclic hematopoiesis.